Search Results - "Peerschke, Ellinor"

Refine Results
  1. 1

    Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology by Ghebrehiwet, Berhane, Peerschke, Ellinor I

    Published in The Journal of clinical investigation (01-11-2020)
    “…In a stunningly short period of time, the unexpected coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  2. 2

    The complement and contact activation systems: partnership in pathogenesis beyond angioedema by Ghebrehiwet, Berhane, Kaplan, Allen P., Joseph, Kusumam, Peerschke, Ellinor I. B.

    Published in Immunological reviews (01-11-2016)
    “…Summary The blood plasma contains four biologically important proteolytic cascades, which probably evolved from the same ancestral gene. This in part may…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage by Frontera, Jennifer A, Lewin III, John J, Rabinstein, Alejandro A, Aisiku, Imo P, Alexandrov, Anne W, Cook, Aaron M, del Zoppo, Gregory J, Kumar, Monisha A, Peerschke, Ellinor I. B, Stiefel, Michael F, Teitelbaum, Jeanne S, Wartenberg, Katja E, Zerfoss, Cindy L

    Published in Neurocritical care (01-02-2016)
    “…BackgroundThe use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is expected…”
    Get full text
    Journal Article
  6. 6

    cC1qR/CR and gC1qR/p33: observations in cancer by Peerschke, Ellinor I B, Ghebrehiwet, Berhane

    Published in Molecular immunology (01-10-2014)
    “…The survival and growth of a primary tumor depends, by and large, on three major events: immune evasion, angiogenesis and metastasis. Tumor cells are "modified…”
    Get full text
    Journal Article
  7. 7

    Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura by Peerschke, Ellinor I. B., Andemariam, Biree, Yin, Wei, Bussel, James B.

    Published in British journal of haematology (01-02-2010)
    “…Summary The role of the complement system in immune thrombocytopenic purpura (ITP) is not well defined. We examined plasma from 79 patients with ITP, 50…”
    Get full text
    Journal Article
  8. 8

    Complement activation on platelets: Implications for vascular inflammation and thrombosis by Peerschke, Ellinor I., Yin, Wei, Ghebrehiwet, Berhane

    Published in Molecular immunology (01-08-2010)
    “…Platelets participate in a variety of responses of the blood to injury. An emerging body of evidence suggests that these cells express an intrinsic capacity to…”
    Get full text
    Journal Article
  9. 9

    C1q as an autocrine and paracrine regulator of cellular functions by Ghebrehiwet, Berhane, Hosszu, Kinga H., Peerschke, Ellinor I.B.

    Published in Molecular immunology (01-04-2017)
    “…•Monocyte/dendritic cell (DC) expressed C1q is a molecular sensor of danger.•Antigen-free C1q keeps DCs in a tolerogenic phenotype.•Danger-­loaded C1q…”
    Get full text
    Journal Article
  10. 10

    SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems by Savitt, Anne G, Manimala, Samantha, White, Tiara, Fandaros, Marina, Yin, Wei, Duan, Huiquan, Xu, Xin, Geisbrecht, Brian V, Rubenstein, David A, Kaplan, Allen P, Peerschke, Ellinor I, Ghebrehiwet, Berhane

    Published in Frontiers in immunology (05-11-2021)
    “…Infection with SARS-CoV-2 triggers the simultaneous activation of innate inflammatory pathways including the complement system and the kallikrein-kinin system…”
    Get full text
    Journal Article
  11. 11

    Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage by Friedrich, Victor, Flores, Rowena, Muller, Artur, Bi, Weina, Peerschke, Ellinor Ib, Sehba, Fatima A

    Published in Journal of neuroinflammation (19-08-2011)
    “…Subarachnoid haemorrhage (SAH) elicits rapid pathological changes in the structure and function of parenchymal vessels (≤ 100 μm). The role of neutrophils in…”
    Get full text
    Journal Article
  12. 12

    Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19 by Peerschke, Ellinor I, Valentino, Alisa, So, Rachel J, Shulman, Scott, Ravinder

    Published in Frontiers in immunology (18-08-2021)
    “…COVID-19 pathology is associated with exuberant inflammation, vascular damage, and activation of coagulation. In addition, complement activation has been…”
    Get full text
    Journal Article
  13. 13

    SLE: Novel Postulates for Therapeutic Options by Hosszu, Kinga K, Valentino, Alisa, Peerschke, Ellinor I, Ghebrehiwet, Berhane

    Published in Frontiers in immunology (07-10-2020)
    “…Genetic deficiency in C1q is a strong susceptibility factor for systemic lupus erythematosus (SLE). There are two major hypotheses that potentially explain the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Reference range determination for whole-blood platelet aggregation using the Multiplate analyzer by Peerschke, Ellinor I B, Castellone, Donna D, Stroobants, A K, Francis, John

    Published in American journal of clinical pathology (01-11-2014)
    “…To develop reference ranges for platelet aggregation using the Multiplate analyzer (Roche Diagnostics, Mannheim, Germany) in blood anticoagulated with sodium…”
    Get full text
    Journal Article
  16. 16

    DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells by Hosszu, Kinga K., Valentino, Alisa, Vinayagasundaram, Uma, Vinayagasundaram, Rama, Joyce, M. Gordon, Ji, Yan, Peerschke, Ellinor I.B., Ghebrehiwet, Berhane

    Published in Blood (09-08-2012)
    “…C1q modulates the differentiation and function of cells committed to the monocyte-derived dendritic cell (DC) lineage. Because the 2 C1q receptors found on the…”
    Get full text
    Journal Article
  17. 17

    HITTING the Diagnosis: Testing for Heparin-Induced Thrombocytopenia in Cancer Patients by Fenelus, Maly, Peerschke, Ellinor I B

    Published in American journal of clinical pathology (03-07-2018)
    “…To evaluate the use of a pretest probability score (4Ts score) in cancer patients to guide ordering of laboratory screening tests for heparin-induced…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer by Ghebrehiwet, Berhane, Zaniewski, Michal, Fernandez, Audrey, DiGiovanni, Mathew, Reyes, Tiana N, Ji, Ping, Savitt, Anne G, Williams, Jennie L, Seeliger, Markus A, Peerschke, Ellinor I B

    Published in Frontiers in immunology (22-04-2024)
    “…Understanding at the molecular level of the cell biology of tumors has led to significant treatment advances in the past. Despite such advances however,…”
    Get full text
    Journal Article
  20. 20

    von Willebrand Factor Assay Proficiency Testing: The North American Specialized Coagulation Laboratory Association Experience by CHANDLER, Wayne L, PEERSCHKE, Ellinor I. B, CASTELLONE, Donna D, MEIJER, Piet

    Published in American journal of clinical pathology (01-06-2011)
    “…We evaluated the accuracy and precision of von Willebrand disease (vWD) testing performed by up to 50 North American Specialty Coagulation Laboratories from…”
    Get full text
    Journal Article